Autologous stem cell transplantation in rheumatoid arthritis

John A. Snowden(Sheffield Teaching Hospitals NHS Foundation Trust), A Tyndall(University Hospital of Basel), Richard K. Burt(Northwestern University), B McKendry, S Pavletics, John J. Moore(Health Net), Patrick Durez(Cliniques Universitaires Saint-Luc), RM Lowenthal, P. Emery, Sarah Bingham, Paul Cannell, Jacob M. van Laar(University Medical Center Utrecht), Passweg
eCite Digital Repository (University of Tasmania)
January 1, 2001
Cited by 5

Related Papers

Guidelines for the diagnosis and management of adult aplastic anaemia
|British Journal of Haematology|2015|750
Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic Sclerosis
|JAMA|2014|739
EULAR definition of difficult-to-treat rheumatoid arthritis
|Annals of the Rheumatic Diseases|2020|538
Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial
|The Lancet|2021|315
Guidelines for the diagnosis and management of multiple myeloma 2011
|British Journal of Haematology|2011|305